Literature DB >> 22616991

Expression of the class II tumor suppressor gene RIG1 is directly regulated by p53 tumor suppressor in cancer cell lines.

Tzu-Hui Hsu1, Chin-Chen Chu, Shun-Yuan Jiang, May-Whey Hung, Wen-Chieh Ni, Huai-En Lin, Tsu-Chung Chang.   

Abstract

Recent studies indicated that the RIG1 (RARRES3/TIG3) plays an important role in cell proliferation, differentiation, and apoptosis. However, the regulatory mechanism of RIG1 gene expression has not been clearly elucidated. In this study, we identified a functional p53 response element (p53RE) in the RIG1 gene promoter. Transfection studies revealed that the RIG1 promoter activity was greatly enhanced by wild type but not mutated p53 protein. Sequence specific mutation of the p53RE abolished p53-mediated transactivation. Specific binding of p53 protein to the rig-p53RE was demonstrated using electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay. Further studies confirmed that the expression of RIG1 mRNA and protein is enhanced through increased p53 protein in HepG2 or in H24-H1299 cells. In conclusion, our results indicated that RIG1 gene is a downstream target of p53 in cancer cell lines.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22616991     DOI: 10.1016/j.febslet.2012.03.020

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cells.

Authors:  T-H Hsu; S-Y Jiang; W-L Chang; W-L Chan; R L Eckert; T M Scharadin; T-C Chang
Journal:  Cell Death Differ       Date:  2014-11-07       Impact factor: 15.828

2.  RARRES3 suppressed metastasis through suppression of MTDH to regulate epithelial-mesenchymal transition in colorectal cancer.

Authors:  Zhengting Wang; Liying Wang; Jiajia Hu; Rong Fan; Jie Zhou; Lei Wang; Jie Zhong
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

3.  The transcription factor p53: not a repressor, solely an activator.

Authors:  Martin Fischer; Lydia Steiner; Kurt Engeland
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  RARRES3 regulates signal transduction through post-translational protein modifications.

Authors:  Tzu-Hui Hsu; Tsu-Chung Chang
Journal:  Mol Cell Oncol       Date:  2015-02-25

5.  Tumor suppressor p53 protects mice against Listeria monocytogenes infection.

Authors:  Shaohui Wang; Pingping Liu; Jianchao Wei; Zixiang Zhu; Zixue Shi; Donghua Shao; Zhiyong Ma
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

6.  Activity-Based Protein Profiling Identifies α-Ketoamides as Inhibitors for Phospholipase A2 Group XVI.

Authors:  Juan Zhou; Elliot D Mock; Andrea Martella; Vasudev Kantae; Xinyu Di; Lindsey Burggraaff; Marc P Baggelaar; Karol Al-Ayed; Alexander Bakker; Bogdan I Florea; Sebastian H Grimm; Hans den Dulk; Chun T Li; Laura Mulder; Herman S Overkleeft; Thomas Hankemeier; Gerard J P van Westen; Mario van der Stelt
Journal:  ACS Chem Biol       Date:  2019-01-18       Impact factor: 5.100

7.  Basal Level p53 Suppresses Antiviral Immunity against Foot-and-Mouth Disease Virus.

Authors:  Tianliang Zhang; Haotai Chen; Xinsheng Liu; Linlin Qi; Xin Gao; Kailing Wang; Kaishen Yao; Jie Zhang; Yuefeng Sun; Yongguang Zhang; Run Wu
Journal:  Viruses       Date:  2019-08-07       Impact factor: 5.048

Review 8.  The HRASLS (PLA/AT) subfamily of enzymes.

Authors:  Emily B Mardian; Ryan M Bradley; Robin E Duncan
Journal:  J Biomed Sci       Date:  2015-10-26       Impact factor: 8.410

9.  Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

Authors:  John Wrangle; Wei Wang; Alexander Koch; Hariharan Easwaran; Helai P Mohammad; Frank Vendetti; Wim Vancriekinge; Timothy Demeyer; Zhengzong Du; Princy Parsana; Kristen Rodgers; Ray-Whay Yen; Cynthia A Zahnow; Janis M Taube; Julie R Brahmer; Scott S Tykodi; Keith Easton; Richard D Carvajal; Peter A Jones; Peter W Laird; Daniel J Weisenberger; Salina Tsai; Rosalyn A Juergens; Suzanne L Topalian; Charles M Rudin; Malcolm V Brock; Drew Pardoll; Stephen B Baylin
Journal:  Oncotarget       Date:  2013-11

10.  The footprint of the ageing stroma in older patients with breast cancer.

Authors:  Barbara Brouwers; Debora Fumagalli; Sylvain Brohee; Sigrid Hatse; Olivier Govaere; Giuseppe Floris; Kathleen Van den Eynde; Yacine Bareche; Patrick Schöffski; Ann Smeets; Patrick Neven; Diether Lambrechts; Christos Sotiriou; Hans Wildiers
Journal:  Breast Cancer Res       Date:  2017-07-03       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.